Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rehab CARES In USA: Clinical Trial

NCT: NCT05542121 · COMPLETED

NCT IDNCT05542121
StatusCOMPLETED
Start Date2022-06-01
Completion2025-08-30
SponsorUniversity of Pennsylvania (OTHER)
First posted
Last updated

Brief Summary

In Phase 2, Patients in a community-based setting who have had a stroke will be evaluated by rehabilitation professionals and asked to perform a battery of clinical assessments before and after standard of care and robot assisted therapy with Rehab CARES system of simple force-feedback robots that are adapted to deliver single and group therapy.

Frequently Asked Questions

What is Rehab CARES In USA: Clinical Trial?

Rehab CARES In USA: Clinical Trial is a clinical trial registered under NCT05542121. Current status: COMPLETED.

What is the status of NCT05542121?

The current status of NCT05542121 (Rehab CARES In USA: Clinical Trial) is: COMPLETED.

When did Rehab CARES In USA: Clinical Trial start?

Rehab CARES In USA: Clinical Trial started on 2022-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.